RecruitingNCT06716996
Magnetic brain stimulation for mood symptoms after COVID
About this title
Read the official source — NCT06716996This study assesses depression symptoms.
Device studyAges 18–65Switzerland
Understand this study
What is this study about?
This study assesses depression symptoms.
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- ZurichSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 14, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 52
- Sponsor
- Flurin Cathomas
- Sponsor type
- Unknown or unclear
- Study type
- Device
- Intervention type
- Device
- Locations
- Switzerland
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06716996
- Official title
Show the full official title
Repeated Transcranial Magnetic Stimulation for the Treatment of Post-COVID Associated Affective Symptoms
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Zurich
Interested in joining this study?
Questions about this study
What is this study about?
This study assesses depression symptoms.
Who is behind this study?
The study sponsor is Flurin Cathomas.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
